26 results
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
12 May 23
Condensed consolidated interim financial statements
6:55pm
breach of a mutual nondisclosure agreement and misappropriation of trade secrets, which has and continues to cause irreparable harm to Plaintiff, which
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
6 May 22
FSD Pharma Inc. 6-K
11:14am
(the “Plaintiff”) on July 20, 2021 in Delaware against the Company and its directors and officers (the “Claim”). In a decision dated May 5, 2022, the Delaware … court dismissed the Claim without prejudice on the grounds that Mr. Maheep Goyal, the Plaintiff, lacked standing to bring his claims.
“We have always
20-F
2021 FY
HUGE
FSD Pharma Inc - Ordinary Shares
31 Mar 22
Annual report (foreign)
8:09am
(the "Settlement Agreement") with respect to a class action litigation commenced by a plaintiff Shareholder in the Ontario Superior Court of Justice … and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action. The Settlement Agreement provided
6-K
EX-99.2
HUGE
FSD Pharma Inc - Ordinary Shares
12 Nov 21
Management's Discussion and Analysis of Financial Condition and Results of
9:48pm
parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action.
Requisitioning
6-K
EX-99.2
2nslp91tq7jalxcnp
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
EX-99.1
qrb3bzi2mp2f2pv
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
EX-99.2
k83gc00
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
EX-99.1
yose6
7 May 21
Condensed consolidated interim financial statements
4:38pm
40-F
EX-99.1
4c51s1
17 Mar 21
Annual report (Canada)
12:00am
40-F
EX-99.2
yaop9b
17 Mar 21
Annual report (Canada)
12:00am
SUPPL
wehqy5mmkf
11 Feb 21
Supplemental materials (foreign)
8:32am
6-K
EX-99.2
5axp65bb
16 Nov 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:59am
6-K
EX-99.3
i8gim eiyqgch9
16 Nov 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:59am
6-K
EX-99.1
83wad6 6wlyxl
16 Nov 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:59am
6-K
EX-99.1
4z9foo lw
29 Oct 20
FSD Pharma Announces Settlement of Class Action Proceeding
4:01pm
6-K
EX-99.2
7971w sadd8pt0472f
11 Aug 20
Management’s Discussion and Analysis of Financial Condition and Results of
12:00am
6-K
EX-99.2
v5y edxndxj95
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
40-F/A
EX-99.2
r9najxlzf 8z
17 Mar 20
Annual report (Canada) (amended)
5:14pm
40-F
EX-99.1
mq32bfw
4 Mar 20
Annual report (Canada)
12:29pm